Skip to main content
PharmaCorp Rx logo

PharmaCorp Rx — Investor Relations & Filings

Ticker · PCRX TSXV Wholesale and retail trade
Open in API
Filings indexed 115 across all filing types
Latest filing 2025-09-26 Capital/Financing Update
Country CA Canada
Listing TSXV PCRX

About PharmaCorp Rx

https://www.pharmacorprx.ca/

PharmaCorp Rx functions as a specialized pharmacy acquisition and ownership platform. Its primary service involves providing comprehensive, personalized succession planning for community pharmacies, facilitating the sale and smooth transition of ownership. The company's model is distinguished by its focus on empowering pharmacists to become equity partners within the acquired entities. PharmaCorp Rx maintains and operates a growing portfolio of retail pharmacies, including those bannered under PharmaChoice, which deliver essential services such as prescription fulfillment and custom compounding specialization.

Recent filings

Filing Released Lang Actions
Preliminary short form prospectus – English.pdf
Capital/Financing Update Classification · 1% confidence The document is a preliminary short form base shelf prospectus detailing the terms and conditions under which PharmaCorp Rx Inc. may offer and sell various securities (common shares, preferred shares, debt securities, warrants, subscription receipts, units) up to an aggregate of $100 million. It is clearly a capital-raising document rather than an annual or interim financial report, earnings release, AGM materials, or regulatory announcement. The prospectus directly relates to fundraising and issuance of securities under Canadian securities legislation. Therefore, it best fits the Capital/Financing Update category.
2025-09-26 English
Qualification certificate.pdf
Regulatory Filings Classification · 1% confidence The document is a Qualification Certificate delivered to multiple Canadian securities regulators to enable the filing of a preliminary short form base shelf prospectus under National Instrument 44-102. It is a regulatory compliance filing rather than a substantive financial report, earnings release, management discussion, or prospectus itself. It does not announce financial results or capital raising amounts; it merely certifies compliance with filing requirements. Therefore, it best fits the fallback category “Regulatory Filings” (RNS).
2025-09-26 English
Other.pdf
Investor Presentation Classification · 1% confidence The document is structured as a slide deck titled “Investor Presentation Q2 2025,” containing forward-looking disclaimers, business overview, growth strategy, market data, non-IFRS measures, and detailed content aimed at investors. It is the full presentation material itself, not a short notice or supplement. This matches the definition of an Investor Presentation (IP).
2025-09-08 English
News release - English.pdf
M&A Activity Classification · 1% confidence The document is a corporate news release entitled “PHARMACORP TO ACQUIRE A PHARMACY…” and details definitive share purchase agreements and letters of intent for multiple pharmacy acquisitions, including purchase prices, closing conditions, and transaction timelines. It is clearly announcing M&A transactions rather than presenting full financial results, an investor presentation, or regulatory disclosures. Key terms: “definitive share purchase agreement,” “letter of intent,” “closing of the Acquisition,” and “Proposed Acquisition” indicate merger and acquisition activity. Therefore, the appropriate category is M&A Activity (Code: TAR).
2025-09-08 English
NI 44-101 Notice of intent to qualify – English.pdf
Capital/Financing Update Classification · 1% confidence The document is a formal notice filed with multiple Canadian securities regulators declaring the issuer’s intention to qualify under NI 44-101 for a short form prospectus distribution. It is not an AGM presentation, call transcript, or management report; rather it relates to a planned financing step (prospectus qualification). This fits the “Capital/Financing Update” category (CAP).
2025-08-01 English
Annual information form - English.pdf
Regulatory Filings Classification · 1% confidence The document is titled 'ANNUAL INFORMATION FORM' (AIF) for PharmaCorp Rx Inc. for the year ended December 31, 2024. In Canadian securities regulation, an Annual Information Form is a disclosure document that provides material information about a company and its business, including its history, operations, and risk factors. While it is an annual disclosure, it is distinct from the 'Annual Report' (10-K) which focuses on audited financial statements. Given the provided categories, 'Regulatory Filings' (RNS) is the most appropriate classification for an AIF as it serves as a formal regulatory disclosure document that does not fit the specific definitions of the other categories like 10-K or IR. FY 2024
2025-07-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.